KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Enterprise Value (2018 - 2025)

Historic Enterprise Value for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$17.2 billion.

  • BioNTech SE's Enterprise Value rose 1651.22% to -$17.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.2 billion, marking a year-over-year increase of 1651.22%. This contributed to the annual value of -$17.9 billion for FY2024, which is 1114.78% up from last year.
  • Latest data reveals that BioNTech SE reported Enterprise Value of -$17.2 billion as of Q3 2025, which was up 1651.22% from -$15.8 billion recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Enterprise Value registered a high of -$1.4 billion during Q3 2021, and its lowest value of -$1459786.9 billion during Q1 2021.
  • Its 5-year average for Enterprise Value is -$76943.1 billion, with a median of -$16.6 billion in 2023.
  • The largest annual percentage gain for BioNTech SE's Enterprise Value in the last 5 years was 9986.99% (2022), contrasted with its biggest fall of 56321.83% (2022).
  • Over the past 5 years, BioNTech SE's Enterprise Value (Quarter) stood at -$2.4 billion in 2021, then crashed by 504.7% to -$14.3 billion in 2022, then plummeted by 40.67% to -$20.2 billion in 2023, then rose by 11.15% to -$17.9 billion in 2024, then increased by 4.15% to -$17.2 billion in 2025.
  • Its last three reported values are -$17.2 billion in Q3 2025, -$15.8 billion for Q2 2025, and -$14.4 billion during Q1 2025.